Showing results (231-240 of 264) with videos related to

Sort By:
Pageof 27
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 23, 2020
Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple MyelomaSusan Bal, Heather J Landau, Gunjan L Shah, et al.
Transplantation and Cellular Therapy|December 20, 2023
Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T TherapyOthman S Akhtar, Karnav Modi, Jongphil Kim, et al.
Eclinicalmedicine|July 24, 2025
Association of dietary macronutrients with MRI-detected vascular brain injury and cognition in 9886 middle-aged participants from four countries: for the Canadian Alliance of Healthy Hearts and Minds (CAHHM) and the Prospective Urban Rural Epidemiological (PURE) Study InvestigatorsVictoria Miller, Eric Smith, Karleen M Schulze, et al.
Nature Communications|September 2, 2023
Immunophenotypic correlates of sustained MRD negativity in patients with multiple myelomaDavid G Coffey, Francesco Maura, Edgar Gonzalez-Kozlova, et al.
Blood Advances|August 12, 2020
Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignanciesTania Jain, Andrea Knezevic, Martina Pennisi, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centersMalin Hultcrantz, Joshua Richter, Cara Rosenbaum, et al.
Plos Pathogens|August 12, 2010
Biological and structural characterization of a host-adapting amino acid in influenza virusShinya Yamada, Masato Hatta, Bart L Staker, et al.
JAMA Network Open|September 17, 2021
Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health SystemChristopher Michael Warren, Theo Thomas Snow, Alexandra S Lee, et al.
Cancer Cell|April 21, 2023
Transcriptional-translational conflict is a barrier to cellular transformation and cancer progressionSujata Jana, Sandipan Brahma, Sonali Arora, et al.
Oncoimmunology|May 1, 2023
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanomaJorge D Oldan, Benjamin C Giglio, Eric Smith, et al.
Pageof 27